(TGTX) TG Therapeutics - Performance 98.3% in 12m
TGTX performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
33.12%
#12 in Peer-Group
Rel. Strength
93.27%
#500 in Stock-Universe
Total Return 12m
98.29%
#14 in Peer-Group
Total Return 5y
79.14%
#17 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 149 |
| P/E Forward | 26.3 |
| High / Low | USD |
|---|---|
| 52 Week High | 45.51 USD |
| 52 Week Low | 17.21 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 36.26 |
| Buy/Sell Signal +-5 | -1.49 |
| Support / Resistance | Levels |
|---|---|
| Support | 34.7, 33.6, 30.6, 24.8, 23.4 |
| Resistance | 39.2, 37.3 |
12m Total Return: TGTX (98.3%) vs XBI (-10.8%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
2.52% | 66.7% | 77.4% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-11.7% | -9.92% | 139% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
-3.21% | -7.33% | 26.4% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
-0.28% | 31.9% | -4.56% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
0.91% | -10.3% | 0.26% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
12.3% | 65.1% | -9.72% | 25.5 | 22.8 | 0.91 | 48.1% | 3.93% |
| PTCT NASDAQ PTC Therapeutics |
0.02% | 56.7% | -7.85% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
2.86% | 34.5% | 14.3% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: TGTX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for TGTX
| Total Return (including Dividends) | TGTX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 0.67% | 2.09% | 4.55% |
| 3 Months | -8.72% | 2.27% | 10.78% |
| 12 Months | 98.29% | -10.84% | 14.71% |
| 5 Years | 79.14% | -26.24% | 112.53% |
| Trend Score (consistency of price movement) | TGTX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -7.9% | 18.8% | 79.2% |
| 3 Months | -25.6% | 71.5% | 92.9% |
| 12 Months | 89.3% | -84.3% | 44.2% |
| 5 Years | -9.3% | -52.7% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th57.50 | -1.39% | -3.71% |
| 3 Month | %th40.50 | -10.75% | -17.61% |
| 12 Month | %th93.50 | 122.39% | 72.86% |
| 5 Years | %th93.50 | 142.89% | -15.71% |
FAQs
Does TG Therapeutics (TGTX) outperform the market?
Yes,
over the last 12 months TGTX made 98.29%, while its related Sector, the SPDR S&P Biotech (XBI) made -10.84%.
Over the last 3 months TGTX made -8.72%, while XBI made 2.27%.
Performance Comparison TGTX vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
TGTX vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -4.5% | -3.9% | 13.5% | 84% |
| US NASDAQ 100 | QQQ | -5.3% | -4.9% | 11.4% | 83% |
| German DAX 40 | DAX | -4.4% | 0.7% | 0.6% | 68% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -4.2% | -3.5% | 15.5% | 81% |
| Hongkong Hang Seng | HSI | -4.1% | -5.1% | -2.2% | 63% |
| India NIFTY 50 | INDA | -4.1% | -1.4% | 13.8% | 98% |
| Brasil Bovespa | EWZ | -5.9% | -7.1% | -11% | 85% |
TGTX vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -6% | -6.1% | 6.9% | 70% |
| Consumer Discretionary | XLY | -2.9% | -1% | 22.2% | 78% |
| Consumer Staples | XLP | -1% | 2.3% | 15.3% | 89% |
| Energy | XLE | -0.1% | -2.8% | 19% | 102% |
| Financial | XLF | -4.6% | -2.4% | 10.4% | 69% |
| Health Care | XLV | -3.6% | -1.4% | 20.7% | 104% |
| Industrial | XLI | -4.1% | -3.1% | 6.9% | 74% |
| Materials | XLB | -2.6% | -1% | 14.2% | 95% |
| Real Estate | XLRE | -0% | 0.7% | 16.2% | 86% |
| Technology | XLK | -5.8% | -8.2% | 10.3% | 86% |
| Utilities | XLU | -2.1% | 0.6% | 10.2% | 74% |
| Aerospace & Defense | XAR | -6.5% | -9.2% | -7.9% | 46% |
| Biotech | XBI | -2.4% | -1.4% | 27.5% | 109% |
| Homebuilder | XHB | -2.8% | -5.4% | 24.8% | 97% |
| Retail | XRT | -1.4% | -0.7% | 22.2% | 92% |
TGTX vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 2.8% | -4.45% | 22.8% | 109% |
| Natural Gas | UNG | 7.7% | 10.1% | 28.7% | 106% |
| Gold | GLD | 0.5% | 2.9% | -6.3% | 57% |
| Silver | SLV | -1.1% | -3.2% | -5% | 76% |
| Copper | CPER | -4.8% | -3.5% | -6.2% | 83% |
TGTX vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -3.3% | -3% | 16.7% | 96% |
| iShares High Yield Corp. Bond | HYG | -2.4% | -1.2% | 14.5% | 87% |